<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="discussion" dtd-version="3.0" xml:lang="EN">
<front>
<journal-meta><journal-id journal-id-type="nlm-ta">PLoS Med</journal-id><journal-id journal-id-type="publisher-id">PLoS</journal-id><journal-id journal-id-type="pmc">plosmed</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Medicine</journal-title></journal-title-group><issn pub-type="epub">1549-1676</issn><publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="publisher-id">09-PLME-ND-1865R2</article-id><article-id pub-id-type="doi">10.1371/journal.pmed.1000176</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neglected Diseases</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Evidence-Based Healthcare</subject><subject>Evidence-Based Healthcare/Clinical Decision-Making</subject><subject>Neurological Disorders/Alzheimer Disease</subject><subject>Neurological Disorders/Cognitive Neurology and Dementia</subject></subj-group></article-categories><title-group><article-title>Packages of Care for Dementia in Low- and Middle-Income Countries</article-title></title-group><contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Prince</surname><given-names>Martin J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Acosta</surname><given-names>Daisy</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Castro-Costa</surname><given-names>Erico</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jackson</surname><given-names>Jim</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Shaji</surname><given-names>K. S.</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib>
</contrib-group><aff id="aff1"><label>1</label><addr-line>Health Service and Population Research Department, Institute of Psychiatry, King's College London, London, United Kingdom</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Universidad Nacional Pedro Henriquez Ureña (UNPHU), Santo Domingo, Dominican Republic</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>Centro de Pesquisa Rene Rachou/Fiocruz, Belo Horizonte, Minos Gerais, Brazil</addr-line>       </aff><aff id="aff4"><label>4</label><addr-line>Alzheimer Scotland, Edinburgh, United Kingdom</addr-line>       </aff><aff id="aff5"><label>5</label><addr-line>Medical College, Thrissur, India</addr-line>       </aff><contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Patel</surname><given-names>Vikram</given-names></name>
<role>Academic Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group><aff id="edit1">London School of Hygiene and Tropical Medicine, United Kingdom</aff><author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">m.prince@iop.kcl.ac.uk</email></corresp>
<fn fn-type="con"><p><ext-link ext-link-type="uri" xlink:href="http://www.icmje.org/" xlink:type="simple">ICMJE</ext-link> criteria for authorship read and met: MJP DA ECC JJ KS. Wrote the first draft of the paper: MJP. Contributed to the writing of the paper: MJP DA ECC JJ KS.</p></fn>
<fn fn-type="conflict"><p>DA is Chair of Alzheimer's Disease International. JJ is the ex-Chief Executive of Alzheimer Scotland.</p></fn></author-notes><pub-date pub-type="collection"><month>11</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>3</day><month>11</month><year>2009</year></pub-date><volume>6</volume><issue>11</issue><elocation-id>e1000176</elocation-id><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2009</copyright-year><copyright-holder>Prince et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract abstract-type="toc">
<p>In the fifth in a series of six articles on packages of care for mental disorders in low- and middle-income countries, Martin Prince and colleagues discuss the treatment of dementia.</p>
</abstract><funding-group><funding-statement>No specific funding was received for this piece.</funding-statement></funding-group><counts><page-count count="9"/></counts></article-meta>
</front>
<body><sec id="s1">
<title/>
<disp-quote>
<p><italic>This is the fifth in a series of articles highlighting the delivery of “packages of care” for mental health disorders in low- and middle-income countries. Packages of care are combinations of treatments aimed at improving the recognition and management of conditions to achieve optimal outcomes.</italic></p>
</disp-quote><boxed-text id="pmed-1000176-box001" position="float"><sec id="s1a1">
<title>Summary Points</title>
<list list-type="bullet"><list-item>
<p>Two-thirds of people with dementia live in low- and middle-income countries (LMICs), where there are few services available and levels of awareness and help-seeking are low.</p>
</list-item><list-item>
<p>After early diagnosis, the principal goals for management of dementia are optimising physical health, cognition, activity, and wellbeing; detecting and treating behavioural and psychological symptoms (BPSD); and providing information and long-term support to carers.</p>
</list-item><list-item>
<p>Routine packages of continuing care should comprise diagnosis coupled with information, regular needs assessments, physical health checks, and carer support, and where necessary carer training, respite care, and assessment and treatment of BPSD.</p>
</list-item><list-item>
<p>Care can be delivered by trained primary care teams working in a collaborative care framework. Continuing care with practice-based care coordination, and community outreach are essential components of this model.</p>
</list-item><list-item>
<p>Efficient care delivery in LMICs involves integrating dementia care with that of other chronic diseases and community-support programs for the elderly and disabled.</p>
</list-item></list>
</sec></boxed-text></sec><sec id="s2">
<title>Introduction</title>
<p>Dementia is a chronic organic brain syndrome, characterised by progressive impairment of multiple cortical functions, including memory, learning, orientation, language, comprehension, and judgement. Diagnosis requires decline in cognitive function and independent living skills (<xref ref-type="boxed-text" rid="pmed-1000176-box002">Box 1</xref>) <xref ref-type="bibr" rid="pmed.1000176-World1">[1]</xref>. However, for carers and people with dementia, the behavioural and psychological symptoms of dementia (BPSD) affect most quality of life, are an important cause of carer strain <xref ref-type="bibr" rid="pmed.1000176-Ferri1">[2]</xref>, and a common reason for institutionalisation <xref ref-type="bibr" rid="pmed.1000176-deVugt1">[3]</xref>. Alzheimer's disease, vascular dementia, dementia with Lewy bodies, and frontotemporal dementia are the most common dementia subtypes, but mixed pathologies may be the norm <xref ref-type="bibr" rid="pmed.1000176-Neuropathology1">[4]</xref>. Some rare causes (subdural haematoma, normal pressure hydrocephalus, hypercalcaemia, and deficiencies of thyroid hormone, vitamin B12, and folic acid) can be treated. Otherwise, the progressive course of dementia cannot be altered, but symptomatic treatments and support can be helpful.</p>
<boxed-text id="pmed-1000176-box002" position="float"><sec id="s2a1">
<title>Box 1. International Classification of Diseases 10 Criteria for Dementia and Commonly Occurring Features</title>
<sec id="s2a1a">
<title>Diagnostic criteria (ICD-10 Diagnostic Guidelines)</title>
<p>“The primary requirement for diagnosis is evidence of a decline in both memory and thinking which is sufficient to impair personal activities of daily living. The impairment of memory typically affects the registration, storage, and retrieval of new information, but previously learned and familiar material may also be lost, particularly in the later stages. There is also impairment of thinking and of reasoning capacity, and a reduction in the flow of ideas. The processing of incoming information is impaired, in that the individual finds it increasingly difficult to attend to more than one stimulus at a time, such as taking part in a conversation with several persons, and to shift the focus of attention from one topic to another. If dementia is the sole diagnosis, evidence of clear consciousness is required. The above symptoms and impairments should have been evident for at least 6 months for a confident clinical diagnosis of dementia to be made” <xref ref-type="bibr" rid="pmed.1000176-World1">[1]</xref>.</p>
<p>The diagnostic criteria do not convey a sense of the typical progression of the disorder:</p>
<p><bold>A person with mild dementia</bold> has noticed deterioration in their memory for recent events. For example, they may forget that their daughter had visited the previous day. They also find it difficult to concentrate, think flexibly, plan, and take decisions. They are likely to feel bewildered, anxious and sad. They may become angry and defensive when others point out errors.</p>
<p><bold>A person with moderate dementia</bold> has severe memory problems. Only early memories are retained. Recent events are not remembered, or rapidly forgotten. They may not know the day, date or time of day. They often do not know where they are. They cannot communicate clearly, having problems finding the right word and using the wrong words. They may hear voices or see things that are not there, and can develop false beliefs, for example that children are entering their house and stealing things. They are likely to be anxious, sad, bewildered, and can become agitated or aggressive.</p>
<p><bold>A person with severe dementia</bold> has complete memory loss. They may no longer recognise their close family. They have severe speech difficulties or are unable to communicate. They may be apathetic and totally inactive, but at times can be agitated and verbally and physically aggressive. They cannot coordinate their physical movements; may have lost the ability to walk and feed themselves and have difficulty swallowing. They are likely to be incontinent.</p>
</sec></sec></boxed-text>
<p>Dementia mainly affects older people. Few cases start before the age of 65 y, after which prevalence doubles with every 5-y increase in age <xref ref-type="bibr" rid="pmed.1000176-Ritchie1">[5]</xref>. Globally, 24.3 million people are affected by dementia and 4.6 million new cases occur annually <xref ref-type="bibr" rid="pmed.1000176-Ferri2">[6]</xref>. The prevalence of dementia is expected to double every 20 y, reaching 81.1 million by 2040, an increase of 100% in developed countries and of more than 300% in India, China, and their neighbours. Prevalence is lower in low- and middle-income countries (LMICs) than in high income countries (HICs) <xref ref-type="bibr" rid="pmed.1000176-Ferri2">[6]</xref>, perhaps because of underdetection of mild cases <xref ref-type="bibr" rid="pmed.1000176-LlibreRodriguez1">[7]</xref>. Nevertheless, most people with dementia live in LMICs—60% in 2001 rising to 71% by 2040 <xref ref-type="bibr" rid="pmed.1000176-Ferri2">[6]</xref>.</p>
<p>Dementia contributes 11.2% of years lived with disability among people aged 60 y and over, a higher proportion than stroke (9.5%), musculoskeletal disorders (8.9%), cardiovascular disease (5.0%), and cancer (2.4%) <xref ref-type="bibr" rid="pmed.1000176-1">[8]</xref>. Its global cost is estimated to be US$317 billion, 77% of this total arising in HICs where formal sector care costs increase with disease progression, and institutionalization is the main cost driver <xref ref-type="bibr" rid="pmed.1000176-Wimo1">[9]</xref>. Family care is more important in resource-poor countries, accounting for 56% of costs in low-income countries, 42% in middle-income countries, and 31% in HICs <xref ref-type="bibr" rid="pmed.1000176-Wimo1">[9]</xref>. In a pilot study in 26 LMIC centers, carers were economically disadvantaged <xref ref-type="bibr" rid="pmed.1000176-10661">[10]</xref>. A fifth of carers had cut back on paid work, and paid carers were common, which added to the economic strain <xref ref-type="bibr" rid="pmed.1000176-10661">[10]</xref>. Compensatory benefits were practically nonexistent <xref ref-type="bibr" rid="pmed.1000176-10661">[10]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Prince1">[11]</xref>.</p>
<p>In three qualitative studies in India, features of dementia were widely recognized and named <xref ref-type="bibr" rid="pmed.1000176-Cohen1">[12]</xref>–<xref ref-type="bibr" rid="pmed.1000176-Shaji1">[14]</xref>. However, dementia was perceived as normal ageing rather than as a medical condition. The consequences were limited help seeking <xref ref-type="bibr" rid="pmed.1000176-Patel1">[13]</xref> despite disability and carer strain <xref ref-type="bibr" rid="pmed.1000176-Prince2">[15]</xref>, no structured training on the recognition and management of dementia, and no constituency to advocate for more responsive care services <xref ref-type="bibr" rid="pmed.1000176-Shaji1">[14]</xref>. People with dementia were excluded from residential care <xref ref-type="bibr" rid="pmed.1000176-Patel1">[13]</xref>. Carers misinterpreted BPSD as deliberate misbehavior <xref ref-type="bibr" rid="pmed.1000176-Shaji1">[14]</xref>. BPSD can also lead to stigma and blame attaching to the carers <xref ref-type="bibr" rid="pmed.1000176-Ferri1">[2]</xref>. In India, likely causes of dementia were cited as “neglect by family members, abuse, tension and lack of love” <xref ref-type="bibr" rid="pmed.1000176-Patel1">[13]</xref>.</p>
<p>In this article, we focus on the effective management of dementia in LMICs, reviewing the evidence on efficacy of interventions and their delivery derived from LMICs where possible. Given the paucity of relevant evidence from LMICs, we also cite systematic reviews and meta-analyses based on trials from HICs. On the basis of our review we propose a package of care—a combination of treatments aimed at improving the recognition and management of conditions to achieve optimal outcomes—for dementia.</p>
</sec><sec id="s3">
<title>The Evidence on the Management of Dementia</title>
<p>The principal goals of management of dementia are: early diagnosis; optimization of physical health, cognition, activity, and wellbeing; detection and treatment of BPSD; and the provision of information and long-term support to carers. The evidence base for dementia care comes, overwhelmingly, from HICs (<xref ref-type="table" rid="pmed-1000176-t001">Table 1</xref>). All the studies discussed below refer to HICs, unless otherwise specified.</p>
<table-wrap id="pmed-1000176-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.1000176.t001</object-id><label>Table 1</label><caption>
<title>The evidence in support of dementia management.</title>
</caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pmed-1000176-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.1000176.t001" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Outcome</td>
<td align="left" colspan="1" rowspan="1">Intervention</td>
<td align="left" colspan="1" rowspan="1">Evidence from HICs</td>
<td align="left" colspan="1" rowspan="1">Evidence from LMICs</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Identifying dementia</bold></td>
<td align="left" colspan="1" rowspan="1">Validity of screening measures</td>
<td align="left" colspan="1" rowspan="1">Systematic review of screening properties of brief cognitive test and informant screening assessments, validated in general practice or community settings <xref ref-type="bibr" rid="pmed.1000176-Brodaty1">[25]</xref></td>
<td align="left" colspan="1" rowspan="1">Adapted versions of the Mini Mental State Examination in India, China, Brazil <xref ref-type="bibr" rid="pmed.1000176-Ganguli1">[20]</xref>–<xref ref-type="bibr" rid="pmed.1000176-CastroCosta1">[22]</xref>; Community Screening Instrument for Dementia (CSID) <xref ref-type="bibr" rid="pmed.1000176-Hall1">[102]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Prince5">[103]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Assessing needs</bold></td>
<td align="left" colspan="1" rowspan="1">Camberwell Assessment of Needs in the Elderly (CANE)</td>
<td align="left" colspan="1" rowspan="1">Development, reliability, and validity in UK, US, and Sweden <xref ref-type="bibr" rid="pmed.1000176-Reynolds1">[104]</xref></td>
<td align="left" colspan="1" rowspan="1">Feasibility and reliability in Brazil, community study <xref ref-type="bibr" rid="pmed.1000176-Sousa1">[94]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Cognitive impairment</bold></td>
<td align="left" colspan="1" rowspan="1">ChEIs</td>
<td align="left" colspan="1" rowspan="1">Meta-analyses of RCTs of donepezil, rivastigmine, and galantamine in Alzheimer's disease <xref ref-type="bibr" rid="pmed.1000176-Birks1">[48]</xref>–<xref ref-type="bibr" rid="pmed.1000176-Birks3">[51]</xref>; Meta-analysis of RCTs of donepezil, rivastigmine, and galantamine for vascular cognitive impairment <xref ref-type="bibr" rid="pmed.1000176-Kavirajan1">[57]</xref></td>
<td align="left" colspan="1" rowspan="1">Small RCT of donepezil in Brazil <xref ref-type="bibr" rid="pmed.1000176-Moraes1">[52]</xref>; Open label trials of galantamine in Brazil <xref ref-type="bibr" rid="pmed.1000176-Caramelli1">[53]</xref> and China <xref ref-type="bibr" rid="pmed.1000176-Chu1">[54]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Memantine</td>
<td align="left" colspan="1" rowspan="1">Meta-analysis of RCTs of memantine <xref ref-type="bibr" rid="pmed.1000176-McShane1">[56]</xref>; Meta-analysis of RCTs of memantine for vascular cognitive impairment <xref ref-type="bibr" rid="pmed.1000176-Kavirajan1">[57]</xref></td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Nonpharmacological interventions</td>
<td align="left" colspan="1" rowspan="1">Meta-analysis of RCTs of reminiscence therapy <xref ref-type="bibr" rid="pmed.1000176-Woods1">[47]</xref>; RCT of cognitive stimulation <xref ref-type="bibr" rid="pmed.1000176-Spector1">[44]</xref>; Meta-analyses of RCTs of cognitive training and rehabilitation <xref ref-type="bibr" rid="pmed.1000176-Clare1">[46]</xref><xref ref-type="table-fn" rid="nt101">a</xref></td>
<td align="left" colspan="1" rowspan="1">Small pilot trial of cognitive stimulation in Brazil <xref ref-type="bibr" rid="pmed.1000176-Bottino1">[45]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Behavioural symptoms</bold></td>
<td align="left" colspan="1" rowspan="1">Conventional antipsychotic drugs</td>
<td align="left" colspan="1" rowspan="1">Meta-analysis of RCTs of haloperidol <xref ref-type="bibr" rid="pmed.1000176-Lonergan1">[60]</xref></td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Atypical (second-generation) antipsychotic drugs</td>
<td align="left" colspan="1" rowspan="1">Meta-analyses of RCTs of risperidone, olanzapine, quetiapine, and aripiprazole for the treatment of BPSD, aggression, and agitation <xref ref-type="bibr" rid="pmed.1000176-Ballard3">[61]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Schneider1">[62]</xref></td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">ChEIs</td>
<td align="left" colspan="1" rowspan="1">Meta-analysis of RCTs of ChEIs for the treatment of BPSD <xref ref-type="bibr" rid="pmed.1000176-Birks3">[51]</xref></td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Memantine</td>
<td align="left" colspan="1" rowspan="1">Meta-analyses of RCTs of memantine in severe dementia <xref ref-type="bibr" rid="pmed.1000176-McShane1">[56]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Wilcock1">[58]</xref></td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">SSRI antidepressants</td>
<td align="left" colspan="1" rowspan="1">Small RCT of citalopram for the treatment of agitation <xref ref-type="bibr" rid="pmed.1000176-Pollock1">[73]</xref>; Meta-analysis of RCTs of trazodone <xref ref-type="bibr" rid="pmed.1000176-MartinonTorres1">[72]</xref>a; RCT of sertraline <xref ref-type="bibr" rid="pmed.1000176-Finkel1">[74]</xref>a</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Anticonvulsants</td>
<td align="left" colspan="1" rowspan="1">Two small RCTs of carbamezepine <xref ref-type="bibr" rid="pmed.1000176-Tariot1">[76]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Olin1">[77]</xref></td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Environmental/sensory interventions</td>
<td align="left" colspan="1" rowspan="1">Meta-analysis of RCTs of massage and light touch <xref ref-type="bibr" rid="pmed.1000176-Viggo1">[81]</xref>; Meta-analysis of the efficacy of aroma therapy <xref ref-type="bibr" rid="pmed.1000176-Thorgrimsen1">[105]</xref>; Meta-analysis of RCTs of Snoezelen (multisensory stimulation) <xref ref-type="bibr" rid="pmed.1000176-Chung1">[79]</xref><xref ref-type="table-fn" rid="nt101">a</xref>; Meta-analysis of RCTs of light therapy <xref ref-type="bibr" rid="pmed.1000176-Forbes1">[78]</xref><xref ref-type="table-fn" rid="nt101">a</xref></td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Depression</bold></td>
<td align="left" colspan="1" rowspan="1">Antidepressant pharmacotherapy</td>
<td align="left" colspan="1" rowspan="1">Meta-analysis of RCTs of antidepressants to treat depression in dementia <xref ref-type="bibr" rid="pmed.1000176-Bains1">[70]</xref><xref ref-type="table-fn" rid="nt101">a</xref></td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Carer interventions</td>
<td align="left" colspan="1" rowspan="1">Meta-analyses of RCTs and nonrandomised trials of carer interventions for improving mood in the care recipient <xref ref-type="bibr" rid="pmed.1000176-Pinquart1">[84]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Brodaty2">[86]</xref></td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Psychosis</bold></td>
<td align="left" colspan="1" rowspan="1">Atypical antipsychotic drugs</td>
<td align="left" colspan="1" rowspan="1">Meta-analyses of RCTs of atypical antipsychotic drugs for the treatment of psychosis in Alzheimer's disease <xref ref-type="bibr" rid="pmed.1000176-Ballard3">[61]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Schneider1">[62]</xref></td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Carer strain, subjective wellbeing, and psychological morbidity</bold></td>
<td align="left" colspan="1" rowspan="1">Carer interventions</td>
<td align="left" colspan="1" rowspan="1">Meta-analyses of controlled studies (including nonrandomised trials) of carer interventions in general <xref ref-type="bibr" rid="pmed.1000176-Brodaty2">[86]</xref> and the specific effects of psychoeducational, interventions, CBT, counselling, and respite care <xref ref-type="bibr" rid="pmed.1000176-Pinquart1">[84]</xref>; Meta-analysis of RCTs of respite care <xref ref-type="bibr" rid="pmed.1000176-Lee1">[87]</xref><xref ref-type="table-fn" rid="nt101">a</xref></td>
<td align="left" colspan="1" rowspan="1">Two small RCTs of a carer education and training intervention in Goa, India <xref ref-type="bibr" rid="pmed.1000176-Dias1">[89]</xref> and in Moscow, Russia <xref ref-type="bibr" rid="pmed.1000176-Gavrilova1">[90]</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Institutionalisation</bold></td>
<td align="left" colspan="1" rowspan="1">Carer intervention</td>
<td align="left" colspan="1" rowspan="1">Meta-analysis of controlled studies (including nonrandomised trials) of carer interventions in preventing or delaying institutionalisation <xref ref-type="bibr" rid="pmed.1000176-Pinquart1">[84]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Spijker1">[88]</xref></td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
</tbody>
</table></alternatives><table-wrap-foot><fn id="nt101"><label>a</label><p>The evidence from these trials and meta-analyses is inconclusive, usually because of a combination of the following factors: small trials; small number of trials; flawed methodology (see text for details).</p></fn><fn id="nt102"><label/><p>SSRI, selective serotonin reuptake inhibitor.</p></fn></table-wrap-foot></table-wrap><sec id="s3a">
<title>Detection and Diagnosis of Dementia</title>
<p>Many cases of dementia, particularly in LMICs, go undetected,in part because of lack of awareness. Awareness of this disorder can be boosted by dissemination of information from governments, health care providers, and media. Help-seeking can be encouraged by improved case-finding. In India and Brazil, for example, community health care workers could, with a few hours training, identify dementia in the community with a positive predictive value of 66% <xref ref-type="bibr" rid="pmed.1000176-Shaji2">[16]</xref>,<xref ref-type="bibr" rid="pmed.1000176-RamosCerqueira1">[17]</xref>. Population screening for dementia is not considered cost-effective even in HICs <xref ref-type="bibr" rid="pmed.1000176-National1">[18]</xref>. Selective screening can be accomplished by cognitive testing or by informant report of cognitive and functional decline. The Mini-Mental State Examination <xref ref-type="bibr" rid="pmed.1000176-Folstein1">[19]</xref> is widely used in HICs, and adapted versions have been developed for use in many LMICs <xref ref-type="bibr" rid="pmed.1000176-Ganguli1">[20]</xref>–<xref ref-type="bibr" rid="pmed.1000176-CastroCosta1">[22]</xref>. However, this assessment takes 10 min to administer and is prone to educational and cultural bias <xref ref-type="bibr" rid="pmed.1000176-Ng1">[23]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Black1">[24]</xref>. A systematic review of brief screening assessments identified three tests (the General Practitioner Assessment of Cognition, Mini-Cog, and Memory Impairment Screen) that took less than 5 min to administer and were considered suitable and valid for routine use in general practice <xref ref-type="bibr" rid="pmed.1000176-Brodaty1">[25]</xref>; none of these tests has been validated in LMICs.</p>
<p>Dementia diagnosis requires cognitive testing, clinical interview, informant interview, and physical examination. The 10/66 Dementia Research Group's culture- and education-fair diagnostic protocol is validated in many LMICs <xref ref-type="bibr" rid="pmed.1000176-Prince3">[26]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Liu1">[27]</xref>, but requires adaptation for clinical use. Practice guidelines in HICs <xref ref-type="bibr" rid="pmed.1000176-National1">[18]</xref> advocate a routine “dementia screen” to exclude treatable causes, which includes haematology, biochemistry, thyroid function tests, vitamin B12 and folate levels. The feasibility and cost-effectiveness of this approach needs to be tested in LMICs.</p>
<p>Finally, a recent systematic review based on evidence collected in HICs identified good practice for disclosing dementia diagnosis. This practice should include: preparation; integrating family members; exploring the patient's perspective; disclosing the diagnosis; responding to patient reactions; focusing on quality of life and wellbeing; planning for the future; and communicating effectively <xref ref-type="bibr" rid="pmed.1000176-Lecouturier1">[28]</xref>. The person assessed should be asked if they, and/or others wish to be told the diagnosis. If so, they should be given information about the signs, symptoms, and course of dementia, available treatments, care and support services.</p>
</sec><sec id="s3b">
<title>Physical Assessment</title>
<p>To avoid missing underlying conditions, a physical assessment is recommended before specific treatments for BPSD are initiated <xref ref-type="bibr" rid="pmed.1000176-Ballard1">[29]</xref>, and should be a regular part of care for all patients. BPSD may sometimes be caused by pain, constipation, and urinary tract infection, although such associations are not always observed <xref ref-type="bibr" rid="pmed.1000176-Leonard1">[30]</xref>. Pain is common and poorly controlled in severe dementia <xref ref-type="bibr" rid="pmed.1000176-Husebo1">[31]</xref>. Hearing and visual impairment impede communication and exacerbate disorientation, and deafness predicts rapid cognitive decline <xref ref-type="bibr" rid="pmed.1000176-Peters1">[32]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Uhlmann1">[33]</xref>. Visual and auditory impairment can be associated with hallucinations and delusions <xref ref-type="bibr" rid="pmed.1000176-Chapman1">[34]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Ballard2">[35]</xref>. Studies indicate that all these impairments are overrepresented in people with cognitive impairment <xref ref-type="bibr" rid="pmed.1000176-Eriksson1">[36]</xref>–<xref ref-type="bibr" rid="pmed.1000176-Rait1">[38]</xref>.</p>
<p>There have been very few trials of the effects of physical assessments and interventions on the course of dementia. In a randomised controlled trial (RCT), pain assessment among nursing home residents with dementia was associated with increased analgesic use, reduced pain, and improvements in staff morale <xref ref-type="bibr" rid="pmed.1000176-FuchsLacelle1">[39]</xref>. Uncontrolled studies show that audiological assessment is feasible, that hearing aids can be beneficial <xref ref-type="bibr" rid="pmed.1000176-Allen1">[40]</xref>, and that referral to an optician to improve visual acuity may reduce visual hallucinosis <xref ref-type="bibr" rid="pmed.1000176-Chapman1">[34]</xref>. Nutrition is often impaired because of apathy, aversive feeding behaviours, poor dental health, and dysphagia. Although difficult to sustain, nutritional supplementation improved nutrition among nursing home residents <xref ref-type="bibr" rid="pmed.1000176-Gil1">[41]</xref>; nutritional education for carers had the same effect in the community <xref ref-type="bibr" rid="pmed.1000176-Riviere1">[42]</xref>. A “vascular care” secondary preventive intervention for people with dementia and cerebrovascular disease (part of current good practice guidelines <xref ref-type="bibr" rid="pmed.1000176-National1">[18]</xref>) that addressed hypercholesterolemia, hypertension, smoking, obesity, exercise, and micronutrient deficiency had no impact on subsequent cognition, disability, or institutionalisation <xref ref-type="bibr" rid="pmed.1000176-Richard1">[43]</xref>.</p>
</sec><sec id="s3c">
<title>Psychological Treatments</title>
<p>A well-conducted RCT of cognitive stimulation (reality orientation, games, discussions based on information processing rather than knowledge) conducted in the United Kingdom as a group intervention <xref ref-type="bibr" rid="pmed.1000176-Spector1">[44]</xref>, and a small pilot trial from Brazil <xref ref-type="bibr" rid="pmed.1000176-Bottino1">[45]</xref>, suggest that cognitive benefits from this intervention are similar to those for cholinesterase inhibitors (ChEIs). More specific cognitive training produced no benefits <xref ref-type="bibr" rid="pmed.1000176-Clare1">[46]</xref>. Cognitive rehabilitation, an individualised therapy designed to enhance residual cognitive skills and cope with deficits, showed promise in uncontrolled case series undertaken in HICs <xref ref-type="bibr" rid="pmed.1000176-Clare1">[46]</xref>. A meta-analysis of four trials of reminiscence therapy (the discussion of past activities, events, and experiences) <xref ref-type="bibr" rid="pmed.1000176-Woods1">[47]</xref> provides evidence for short-term improvement in cognition, mood, and carer strain, but the quality of these trials was poor.</p>
</sec><sec id="s3d">
<title>Pharmacological Treatments</title>
<p>Targets for pharmacological treatment include cognitive impairment, behavioural symptoms (agitation and aggression), and psychological symptoms (depression, anxiety, and psychosis).</p>
<p>There is a strong evidence base for the efficacy of ChEIs (donepezil <xref ref-type="bibr" rid="pmed.1000176-Birks1">[48]</xref>, rivastigmine <xref ref-type="bibr" rid="pmed.1000176-Birks2">[49]</xref>, and galantamine <xref ref-type="bibr" rid="pmed.1000176-Loy1">[50]</xref>). The use of each of these drugs is associated with modest and comparable improvements in cognitive function, global clinical state, and activities of daily living <xref ref-type="bibr" rid="pmed.1000176-Birks3">[51]</xref>. The evidence base for ChEIs from LMICs is limited to one small RCT of donepezil in Brazil <xref ref-type="bibr" rid="pmed.1000176-Moraes1">[52]</xref> and open-label trials of galantamine in Brazil <xref ref-type="bibr" rid="pmed.1000176-Caramelli1">[53]</xref> and China <xref ref-type="bibr" rid="pmed.1000176-Chu1">[54]</xref>. The efficacy of this class of drugs in severe dementia is unclear, although useful cognitive benefits were identified for galantamine <xref ref-type="bibr" rid="pmed.1000176-Burns1">[55]</xref>. A fourth drug for the treatment of cognitive impairment, memantine, has a different mode of action, and is well tolerated, but evidence for its efficacy is limited to people with moderate to severe dementia <xref ref-type="bibr" rid="pmed.1000176-McShane1">[56]</xref>. ChEIs and memantine are less efficacious in vascular dementia than in other forms of dementia <xref ref-type="bibr" rid="pmed.1000176-Kavirajan1">[57]</xref>. Their efficacy for the treatment of disturbed behaviour is not established; manufacturer-sponsored licensing trials <xref ref-type="bibr" rid="pmed.1000176-Birks3">[51]</xref> and post hoc analyses <xref ref-type="bibr" rid="pmed.1000176-Wilcock1">[58]</xref> indicate small improvements that have not been confirmed in independent trials <xref ref-type="bibr" rid="pmed.1000176-Howard1">[59]</xref> and meta-analyses <xref ref-type="bibr" rid="pmed.1000176-McShane1">[56]</xref>.</p>
<p>Meta-analyses of RCTs of haloperidol <xref ref-type="bibr" rid="pmed.1000176-Lonergan1">[60]</xref> and atypical antipsychotic drugs for the treatment of agitation <xref ref-type="bibr" rid="pmed.1000176-Ballard3">[61]</xref> and BPSD <xref ref-type="bibr" rid="pmed.1000176-Schneider1">[62]</xref> indicate small treatment effects, most evident for aggression <xref ref-type="bibr" rid="pmed.1000176-Schneider1">[62]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Ballard4">[63]</xref>. Atypical antipsychotic drugs have also been widely prescribed for psychosis in dementia, but a meta-analysis of their efficacy indicated that only aripiprazole had a statistically and clinically significant effect <xref ref-type="bibr" rid="pmed.1000176-Schneider1">[62]</xref>. Use of these drugs in dementia is associated with an increased risk of death and cerebrovascular adverse events <xref ref-type="bibr" rid="pmed.1000176-Schneider1">[62]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Schneider2">[64]</xref>–<xref ref-type="bibr" rid="pmed.1000176-Douglas1">[68]</xref>.</p>
<p>The benefits of antidepressant treatment in older people are clear <xref ref-type="bibr" rid="pmed.1000176-Hunkeler1">[69]</xref>, but a meta-analysis of their efficacy in people with dementia was inconclusive <xref ref-type="bibr" rid="pmed.1000176-Bains1">[70]</xref>. Only two small trials were included in this meta-analysis, one of which suggested a benefit of sertraline for some depression outcomes <xref ref-type="bibr" rid="pmed.1000176-Lyketsos1">[71]</xref>. Antidepressants have also been proposed for the treatment of BPSD. A meta-analysis of two small RCTs of trazodone was inconclusive <xref ref-type="bibr" rid="pmed.1000176-MartinonTorres1">[72]</xref>. Citalopram showed efficacy over placebo for the treatment of agitation in one small RCT <xref ref-type="bibr" rid="pmed.1000176-Pollock1">[73]</xref>, while sertraline showed no benefit on any primary behavioural endpoint <xref ref-type="bibr" rid="pmed.1000176-Finkel1">[74]</xref>.</p>
<p>A systematic review of trials of anticonvulsants to treat BPSD found sodium valproate to be ineffective <xref ref-type="bibr" rid="pmed.1000176-Lonergan2">[75]</xref>. Carbamezepine may be more promising with large benefits noted for global clinical outcomes and agitation in one small parallel group trial <xref ref-type="bibr" rid="pmed.1000176-Tariot1">[76]</xref> and more marginal effects in a small pilot trial <xref ref-type="bibr" rid="pmed.1000176-Olin1">[77]</xref>.</p>
</sec><sec id="s3e">
<title>Sensory Therapy</title>
<p>Various sensory therapies have been proposed as treatments for BPSD but the evidence base for this approach is small and limited by the poor quality of the trials. Current evidence does not support the use of bright light therapy <xref ref-type="bibr" rid="pmed.1000176-Forbes1">[78]</xref> or multisensory stimulation <xref ref-type="bibr" rid="pmed.1000176-Chung1">[79]</xref>. One small RCT of aromatherapy suggested considerable benefit across a range of behavioural outcomes <xref ref-type="bibr" rid="pmed.1000176-Ballard5">[80]</xref>. Another small but well-conducted trial suggested that hand massage may be effective in reducing agitation <xref ref-type="bibr" rid="pmed.1000176-Viggo1">[81]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Remington1">[82]</xref>. More evidence is required to confirm efficacy, exclude the possibility of harm, and define the optimal content and mode of administration of sensory therapies in both HICs and LMICs, where the approach is untested.</p>
</sec><sec id="s3f">
<title>Carer-Focused Interventions</title>
<p>A large literature attests to the benefits of carer interventions in dementia <xref ref-type="bibr" rid="pmed.1000176-Sorensen1">[83]</xref>. These include: psychoeducational interventions, often including carer training; psychological therapies such as cognitive behavioural therapy (CBT) and counselling; carer support; and respite care. Many interventions combine several of these elements. There are several systematic reviews and meta-analyses of these interventions <xref ref-type="bibr" rid="pmed.1000176-Pinquart1">[84]</xref>–<xref ref-type="bibr" rid="pmed.1000176-Spijker1">[88]</xref>; all of the constituent trials in these studies were conducted in HICs, and many were nonrandomised <xref ref-type="bibr" rid="pmed.1000176-Pinquart1">[84]</xref>. Outcomes studied include carer strain, depression, and subjective wellbeing; behaviour disturbance and mood in the care recipient; and institutionalisation. Most carer-focused interventions seemed to reduce carer strain and depression, CBT having the largest impact on depression <xref ref-type="bibr" rid="pmed.1000176-Pinquart1">[84]</xref>. Psychoeducational interventions required the active participation of the carer (for example, in role-playing activities) to be effective <xref ref-type="bibr" rid="pmed.1000176-Pinquart1">[84]</xref>. Carer support increased carer wellbeing but no other outcomes <xref ref-type="bibr" rid="pmed.1000176-Pinquart1">[84]</xref>. For respite care, three methodologically flawed RCTs showed no benefit on any outcome <xref ref-type="bibr" rid="pmed.1000176-Lee1">[87]</xref>. However, nonrandomised studies suggest that respite care significantly reduces carer strain and psychological morbidity <xref ref-type="bibr" rid="pmed.1000176-Pinquart1">[84]</xref>. Interventions targeting the carer may also have small but significant beneficial effects upon the behaviour of the person with dementia <xref ref-type="bibr" rid="pmed.1000176-Pinquart1">[84]</xref>. A systematic review of ten RCTs indicated a 40% reduction in the pooled odds of institutionalisation <xref ref-type="bibr" rid="pmed.1000176-Spijker1">[88]</xref>; the effective interventions were structured, intensive, and multicomponent, offering a choice of services and supports <xref ref-type="bibr" rid="pmed.1000176-Pinquart1">[84]</xref>,<xref ref-type="bibr" rid="pmed.1000176-Spijker1">[88]</xref>. Two small trials in LMICs of a brief carer education and training intervention, one from India <xref ref-type="bibr" rid="pmed.1000176-Dias1">[89]</xref> and one from Russia <xref ref-type="bibr" rid="pmed.1000176-Gavrilova1">[90]</xref> indicated much larger treatment effects on carer psychological morbidity <xref ref-type="bibr" rid="pmed.1000176-Dias1">[89]</xref> and strain <xref ref-type="bibr" rid="pmed.1000176-Gavrilova1">[90]</xref> than typically seen for such interventions in HICs.</p>
</sec></sec><sec id="s4">
<title>Delivery of Effective Interventions</title>
<p>The mechanisms by which effective dementia care treatments may be delivered in LMIC settings are summarized in <xref ref-type="table" rid="pmed-1000176-t002">Table 2</xref>.</p>
<table-wrap id="pmed-1000176-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.1000176.t002</object-id><label>Table 2</label><caption>
<title>Delivering dementia care treatments.</title>
</caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pmed-1000176-t002-2" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.1000176.t002" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Step</td>
<td align="left" colspan="1" rowspan="1">How</td>
<td align="left" colspan="1" rowspan="1">By Whom</td>
<td align="left" colspan="1" rowspan="1">In What Settings</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Increasing demand</bold></td>
<td align="left" colspan="1" rowspan="1">Improve awareness among general population, carers, health professionals</td>
<td align="left" colspan="1" rowspan="1">Alzheimer's associations, other chronic disease NGOs, health professionals, media, government</td>
<td align="left" colspan="1" rowspan="1">Schools</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Combat stigma</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Public arena</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Provide age-appropriate, accessible services</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">General practice, primary care</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Provide disability pensions for people with dementia, and carer benefits</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Professional education institutions</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Increasing capacity of health care teams</bold></td>
<td align="left" colspan="1" rowspan="1">Training of community, primary, and secondary general health care providers (diagnosis, needs assessment, health checks, care package)</td>
<td align="left" colspan="1" rowspan="1">Medical, nursing, and rural health schools</td>
<td align="left" colspan="1" rowspan="1">Primary care</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Paradigm shift to chronic, continuing care</td>
<td align="left" colspan="1" rowspan="1">Dementia specialist clinicians</td>
<td align="left" colspan="1" rowspan="1">Secondary general health care</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Support and supervision from specialists</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Increasing recognition</bold></td>
<td align="left" colspan="1" rowspan="1">Community-based case finding <xref ref-type="bibr" rid="pmed.1000176-Shaji2">[16]</xref>,<xref ref-type="bibr" rid="pmed.1000176-RamosCerqueira1">[17]</xref></td>
<td align="left" colspan="1" rowspan="1">Community health care workers</td>
<td align="left" colspan="1" rowspan="1">Community</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Selective screening in primary and secondary care <xref ref-type="bibr" rid="pmed.1000176-Brodaty1">[25]</xref></td>
<td align="left" colspan="1" rowspan="1">Nonspecialist clinicians</td>
<td align="left" colspan="1" rowspan="1">Primary care</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Specialist centers</td>
<td align="left" colspan="1" rowspan="1">Dementia specialist clinicians</td>
<td align="left" colspan="1" rowspan="1">Secondary general health care</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Memory clinics</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Adapting treatments to increase acceptability or reduce cost</bold></td>
<td align="left" colspan="1" rowspan="1">Integrate dementia prevention and care into new chronic disease programs <xref ref-type="bibr" rid="pmed.1000176-EppingJordan1">[93]</xref></td>
<td align="left" colspan="1" rowspan="1">Community health care workers to deliver carer interventions and act as care coordinators <xref ref-type="bibr" rid="pmed.1000176-Callahan1">[100]</xref></td>
<td align="left" colspan="1" rowspan="1">Community</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Provide outreach (home-based assessment and care)</td>
<td align="left" colspan="1" rowspan="1">Nonspecialist clinicians to diagnose dementia, optimize physical health, assess needs, and plan community support</td>
<td align="left" colspan="1" rowspan="1">Primary care</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Integrate long-term care and support interventions into programs for all dependent elderly</td>
<td align="left" colspan="1" rowspan="1">Carers and other volunteers</td>
<td align="left" colspan="1" rowspan="1">Secondary general health care</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Ensure carer interventions are culturally appropriate <xref ref-type="bibr" rid="pmed.1000176-Dias1">[89]</xref></td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Provide group interventions for carers <xref ref-type="bibr" rid="pmed.1000176-Sorensen1">[83]</xref></td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Develop and use cheaper generic versions of ChEIs and SSRI antidepressants, where available and indicated</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Practice-based programs to deliver effective treatments</bold></td>
<td align="left" colspan="1" rowspan="1">Train primary care staff as dementia and elder care case managers <xref ref-type="bibr" rid="pmed.1000176-Callahan1">[100]</xref></td>
<td align="left" colspan="1" rowspan="1">Primary care case managers</td>
<td align="left" colspan="1" rowspan="1">Primary care</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Establish collaborative care <xref ref-type="bibr" rid="pmed.1000176-Callahan1">[100]</xref> with involvement of specialist teams</td>
<td align="left" colspan="1" rowspan="1">Primary care clinicians</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Primary care health care workers</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">Dementia care specialist</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Community-based programs to deliver effective treatments</bold></td>
<td align="left" colspan="1" rowspan="1">Train carers and establish and support groups</td>
<td align="left" colspan="1" rowspan="1">Community health care workers</td>
<td align="left" colspan="1" rowspan="1">Community</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Home outreach and individualized intervention</td>
<td align="left" colspan="1" rowspan="1">Peer (carer-to-carer) support and training</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Respite at home and homecare</td>
<td align="left" colspan="1" rowspan="1">Community volunteers</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><bold>Addressing impact of the disorder on other health/social outcomes</bold></td>
<td align="left" colspan="1" rowspan="1">Carer interventions</td>
<td align="left" colspan="1" rowspan="1">Government social welfare agencies</td>
<td align="left" colspan="1" rowspan="1">Community</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Carer benefits</td>
<td align="left" colspan="1" rowspan="1">Community health care workers</td>
<td align="left" colspan="1" rowspan="1">Primary care</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Respite care and homecare programs</td>
<td align="left" colspan="1" rowspan="1">Case managers</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Disability benefits and social pensions for older people <xref ref-type="bibr" rid="pmed.1000176-Institute1">[106]</xref></td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Regular physical health checks</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Nutritional interventions</td>
<td align="left" colspan="1" rowspan="1">—</td>
<td align="left" colspan="1" rowspan="1">—</td>
</tr>
</tbody>
</table></alternatives><table-wrap-foot><fn id="nt103"><label/><p>SSRI, selective serotonin reuptake inhibitor.</p></fn></table-wrap-foot></table-wrap><sec id="s4a">
<title>Interventions to Increase Demand for Services</title>
<p>Alzheimer's Disease International has identified raising awareness of dementia among the public, carers, and health workers as a global priority, with an increase in demands for services as one of the intended benefits <xref ref-type="bibr" rid="pmed.1000176-Graham1">[91]</xref>. Awareness can be raised in several ways. The establishment of a critical mass of informed carers can assist awareness-raising, provide advice and support to families, and work with Alzheimer's disease associations to lobby for more services that better meet the needs of carers. Community solidarity can also effect change through support for health and social welfare policies based on equity and justice. Aware communities can provide support and reduce stigma and exclusion. Policymakers can be held to account by media campaigns and advocacy from committed NGOs. In HICs, awareness is growing rapidly, with the media playing an important role <xref ref-type="bibr" rid="pmed.1000176-Prince4">[92]</xref>. Media in LMICs can be receptive to these stories, but efforts are required to alert them to the importance of ageing and dementia, and to build their capacity to report the problem <xref ref-type="bibr" rid="pmed.1000176-Prince4">[92]</xref>.</p>
<p>Intergenerational solidarity can be promoted through awareness-raising among children and young adults. In many LMICs, many people with dementia live in multigenerational households with young children, and children or children-in-law are the most frequent carers for people with dementia <xref ref-type="bibr" rid="pmed.1000176-10661">[10]</xref>, and the most likely to initiate help-seeking. Finally, in LMICs the provision of disability pensions and carer benefits will inevitably increase requests for diagnostic assessment. Importantly, however, efforts to increase awareness must be accompanied by health system and service reform, so that help-seeking is met with a supply of better-prepared, more responsive services.</p>
</sec><sec id="s4b">
<title>Interventions to Improve the Capacity of Health Care Teams</title>
<p>Primary health care services in LMICs often fail older people because they are clinic-based and preoccupied with simple curative interventions <xref ref-type="bibr" rid="pmed.1000176-Patel1">[13]</xref>–<xref ref-type="bibr" rid="pmed.1000176-Prince2">[15]</xref>. A paradigm shift is needed to encompass continuing care and support as part of a wider chronic disease strategy. Given the frailty of many older people with dementia, there is also a need for outreach to assess and manage patients in their own homes. The World Health Organization (WHO) Innovative Care for Chronic Conditions framework <xref ref-type="bibr" rid="pmed.1000176-EppingJordan1">[93]</xref> proposes that the delivery of care for chronic conditions can be improved through a dialogue to build commitment for change, extended and regular health care contact, a multisectoral approach, care centered on patients and families, support for patients in the community, and an emphasis on prevention. Dementia care should be an essential component of such chronic disease care strategies. Training of nonspecialist health professionals should focus on case-finding and on conveying the diagnosis to patients and carers together with information and support, needs assessment, and carer training and support. Training can be service-based as well as through changes to the medical and nursing school, public health, and rural health curricula. Medical and community care services should be planned and coordinated to respond to the increasing need for support as the disease progresses.</p>
</sec><sec id="s4c">
<title>Interventions to Improve Recognition</title>
<p>The focus here should be first upon case-finding by community health workers <xref ref-type="bibr" rid="pmed.1000176-Shaji2">[16]</xref>,<xref ref-type="bibr" rid="pmed.1000176-RamosCerqueira1">[17]</xref>, and then on selective screening coupled with simplified “quasi-diagnostic” algorithms and needs assessments <xref ref-type="bibr" rid="pmed.1000176-Sousa1">[94]</xref> by nonspecialist clinicians. More research is needed to identify the most feasible and valid methods.</p>
</sec><sec id="s4d">
<title>Interventions to Increase the Acceptability and Reduce the Costs of Treatments</title>
<p>At present, the costs of ChEIs are reimbursed in some Latin American countries and Chinese provinces, generic ChEIs are available in India, and Huperzine A, a cheap plant extract with similar properties to ChEIs is used in China <xref ref-type="bibr" rid="pmed.1000176-Kalaria1">[95]</xref>. In what is a very active and promising field for drug development <xref ref-type="bibr" rid="pmed.1000176-Rafii1">[96]</xref>, any new agent with radical disease-modifying properties will be very expensive, which raises important ethical and practical challenges to securing equitable access. An international effort leveraged by grass roots advocacy (similar to that mounted for antiretroviral treatment for HIV) might be required to secure affordable supplies for people with dementia living in LMICs. More positively, costs of primary care and community interventions can be minimised through task-shifting to nonspecialist and paraprofessional staff and integration with more broadly based chronic disease <xref ref-type="bibr" rid="pmed.1000176-EppingJordan1">[93]</xref>, disability, and elder care programmes <xref ref-type="bibr" rid="pmed.1000176-World2">[97]</xref>,<xref ref-type="bibr" rid="pmed.1000176-United1">[98]</xref>. In India a community-based palliative care program has been successfully extended to include dementia care <xref ref-type="bibr" rid="pmed.1000176-Shaji3">[99]</xref>.</p>
</sec><sec id="s4e">
<title>Practice-Based Programs to Deliver Effective Treatment</title>
<p>Most LMICs have insufficient specialists to provide national frontline dementia services. Diagnosis and needs assessment can be conducted in primary care, although increased specialist input to help with advice, inpatient or outpatient review of refractory BPSD, and respite care would be desirable. Routine physical reviews within practice-based programs are important but research is needed into the cost-effectiveness of haematological and biochemical screening, and the feasibility and effectiveness of interventions to improve hearing, vision, nutrition, and continence. A commitment to continuing care is essential, with regular review and physical health and needs assessments. Practice-based case managers can coordinate this process; this collaborative care model reduced BPSD and carer strain in an RCT in the US <xref ref-type="bibr" rid="pmed.1000176-Callahan1">[100]</xref>.</p>
</sec><sec id="s4f">
<title>Community-Based Programs to Deliver Effective Treatments</title>
<p>Carer-support programs can be delivered individually or in groups by community health workers or by experienced carers. Carer strain, whether or not associated with BPSD, should trigger more intensive intervention that includes psychological assessment and depression treatment for the carer <xref ref-type="bibr" rid="pmed.1000176-Patel2">[101]</xref>, respite, and carer education and training. Such interventions could be incorporated into horizontally constructed community-based programs that address the generic needs of frail, dependent older people and their carers, whether these needs arise from cognitive, mental, or physical disorders.</p>
</sec></sec><sec id="s5">
<title>Packages of Care for Dementia in LMICs</title>
<p>On the basis of our review, we have proposed a package of care for LMICs that considers the availability of resources for the detection, diagnosis, and treatment of dementia in this setting. In <xref ref-type="table" rid="pmed-1000176-t003">Table 3</xref>, the main features of this package are compared with typical recommendations for well-resourced HIC settings. To improve care for dementia in LMICs, we propose that the basic package of care should focus upon diagnosis coupled with information, regular needs assessments, physical health checks, and carer support. This package should be extended to include carer training, respite care, and assessment and treatment of BPSD where possible. We suggest that that care can best be delivered by trained primary care teams, with a paradigm shift towards chronic continuing care and community outreach. Practice-based care coordinators are an essential component of this package, ideally working within a collaborative-care framework. Finally, we note that care delivery will be more efficient when integrated with that of other chronic diseases, and more broadly based community-support programs for the elderly and disabled.</p>
<table-wrap id="pmed-1000176-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.1000176.t003</object-id><label>Table 3</label><caption>
<title>Packages of care for dementia.</title>
</caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pmed-1000176-t003-3" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.1000176.t003" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Low Resourced Settings</td>
<td align="left" colspan="1" rowspan="1">High Resourced Settings <xref ref-type="bibr" rid="pmed.1000176-UK1">[107]</xref></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Public information campaigns</td>
<td align="left" colspan="1" rowspan="1">Public information campaigns</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Community case-finding; Primary care diagnosis and needs assessment</td>
<td align="left" colspan="1" rowspan="1">National network of specialist memory services, for diagnosis and as entry point into care pathway</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Provision of information for people with dementia and carers</td>
<td align="left" colspan="1" rowspan="1">Provision of information for people with dementia and carers</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Continuity of support, coordinated by primary care case manager</td>
<td align="left" colspan="1" rowspan="1">Continuity of support, coordinated by specialist case manager</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Regular case review with reassessment of needs; Specialist consultation and referral where available</td>
<td align="left" colspan="1" rowspan="1">Integrated and continuing health and social care by multidisciplinary specialist care team</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cautious use of antipsychotic drugs and other experimental treatments for BPSD, not as first line treatment, and preferably initiated and reviewed by specialists</td>
<td align="left" colspan="1" rowspan="1">Cautious use of antipsychotic drugs and other experimental treatments for BPSD, not as first line treatment, and initiated and reviewed by specialists</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anticholinesterase drug treatment for cognitive impairment is unlikely to be seen as a cost-effective priority within most resource-poor systems</td>
<td align="left" colspan="1" rowspan="1">Anticholinesterase drugs for memory impairment, when considered cost-effective, with specialist initiation and review</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Carer-support groups; Individualised community-based carer interventions and support</td>
<td align="left" colspan="1" rowspan="1">Comprehensive carer's strategy for people with dementia; Community personal support</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Promote access to general health care</td>
<td align="left" colspan="1" rowspan="1">Effective care in general hospitals, intermediate care and care homes. Effective end of life care</td>
</tr>
</tbody>
</table></alternatives></table-wrap></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pmed.1000176-World1"><label>1</label><element-citation publication-type="other" xlink:type="simple">             <collab xlink:type="simple">World Health Organization</collab>             <year>1992</year>             <source>International classification of diseases (10th Revision)</source>             <publisher-loc>Geneva</publisher-loc>             <publisher-name>World Health Organization</publisher-name>          </element-citation></ref>
<ref id="pmed.1000176-Ferri1"><label>2</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ferri</surname><given-names>CP</given-names></name>
<name name-style="western"><surname>Ames</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Prince</surname><given-names>M</given-names></name>
</person-group>             <year>2004</year>             <article-title>Behavioral and psychological symptoms of dementia in developing countries.</article-title>             <source>Int Psychogeriatr</source>             <volume>16</volume>             <fpage>441</fpage>             <lpage>459</lpage>          </element-citation></ref>
<ref id="pmed.1000176-deVugt1"><label>3</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>de Vugt</surname><given-names>ME</given-names></name>
<name name-style="western"><surname>Stevens</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Aalten</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Lousberg</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Jaspers</surname><given-names>N</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>A prospective study of the effects of behavioral symptoms on the institutionalization of patients with dementia.</article-title>             <source>Int Psychogeriatr</source>             <volume>17</volume>             <fpage>577</fpage>             <lpage>589</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Neuropathology1"><label>4</label><element-citation publication-type="journal" xlink:type="simple">             <collab xlink:type="simple">Neuropathology Group Medical Research Council Cognitive Function and Aging Study</collab>             <year>2001</year>             <article-title>Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) [comment].</article-title>             <source>Lancet</source>             <volume>357</volume>             <fpage>169</fpage>             <lpage>175</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Ritchie1"><label>5</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ritchie</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Kildea</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Robine</surname><given-names>JM</given-names></name>
</person-group>             <year>1992</year>             <article-title>The relationship between age and the prevalence of senile dementia: a meta-analysis of recent data.</article-title>             <source>Int J Epidemiol</source>             <volume>21</volume>             <fpage>763</fpage>             <lpage>769</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Ferri2"><label>6</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ferri</surname><given-names>CP</given-names></name>
<name name-style="western"><surname>Prince</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Brayne</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Brodaty</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Fratiglioni</surname><given-names>L</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Global prevalence of dementia: a Delphi consensus study.</article-title>             <source>Lancet</source>             <volume>366</volume>             <fpage>2112</fpage>             <lpage>2117</lpage>          </element-citation></ref>
<ref id="pmed.1000176-LlibreRodriguez1"><label>7</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Llibre Rodriguez</surname><given-names>JJ</given-names></name>
<name name-style="western"><surname>Ferri</surname><given-names>CP</given-names></name>
<name name-style="western"><surname>Acosta</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Guerra</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey.</article-title>             <source>Lancet</source>             <volume>372</volume>             <fpage>464</fpage>             <lpage>474</lpage>          </element-citation></ref>
<ref id="pmed.1000176-1"><label>8</label><element-citation publication-type="other" xlink:type="simple">             <year>1996</year>             <source>The Global Burden of Disease. A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020</source>             <publisher-loc>Cambridge (Massachusetts)</publisher-loc>             <publisher-name>Harvard School of Public Health, Harvard University Press</publisher-name>          </element-citation></ref>
<ref id="pmed.1000176-Wimo1"><label>9</label><element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wimo</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Winblad</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Jonsson</surname><given-names>L</given-names></name>
</person-group>             <year>2007</year>             <article-title>An estimate of the total worldwide societal costs of dementia in 2005.</article-title>             <comment>Alzheimer's and Dementia 81–91</comment>          </element-citation></ref>
<ref id="pmed.1000176-10661"><label>10</label><element-citation publication-type="journal" xlink:type="simple">             <collab xlink:type="simple">10/66 Dementia Research Group</collab>             <year>2004</year>             <article-title>Care arrangements for people with dementia in developing countries.</article-title>             <source>Int J Geriatr Psychiatry</source>             <volume>19</volume>             <fpage>170</fpage>             <lpage>177</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Prince1"><label>11</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Prince</surname><given-names>MJ</given-names></name>
</person-group>             <year>2009</year>             <article-title>The 10/66 dementia research group - 10 years on.</article-title>             <source>Indian Journal of Psychiatry</source>             <volume>51</volume>             <fpage>S8</fpage>             <lpage>S15</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Cohen1"><label>12</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cohen</surname><given-names>L</given-names></name>
</person-group>             <year>1995</year>             <article-title>Toward an anthropology of senility: anger, weakness, and Alzheimer's in Banaras, India.</article-title>             <source>Med Anthropol Q</source>             <volume>9</volume>             <fpage>314</fpage>             <lpage>334</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Patel1"><label>13</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Patel</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Prince</surname><given-names>M</given-names></name>
</person-group>             <year>2001</year>             <article-title>Ageing and mental health in a developing country: who cares? Qualitative studies from Goa, India.</article-title>             <source>Psychol Med</source>             <volume>31</volume>             <fpage>29</fpage>             <lpage>38</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Shaji1"><label>14</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Shaji</surname><given-names>KS</given-names></name>
<name name-style="western"><surname>Smitha</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Praveen Lal</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Prince</surname><given-names>M</given-names></name>
</person-group>             <year>2002</year>             <article-title>Caregivers Of patients with Alzheimer's disease: a qualitative study from the Indian 10/66 Dementia Research Network.</article-title>             <source>Int J Geriatr Psych</source>             <volume>18</volume>             <fpage>1</fpage>             <lpage>6</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Prince2"><label>15</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Prince</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Livingston</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Katona</surname><given-names>C</given-names></name>
</person-group>             <year>2007</year>             <article-title>Mental health care for the elderly in low-income countries: a health systems approach.</article-title>             <source>World Psychiatry</source>             <volume>6</volume>             <fpage>5</fpage>             <lpage>13</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Shaji2"><label>16</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Shaji</surname><given-names>KS</given-names></name>
<name name-style="western"><surname>Arun Kishore</surname><given-names>NR</given-names></name>
<name name-style="western"><surname>Lal</surname><given-names>KP</given-names></name>
<name name-style="western"><surname>Prince</surname><given-names>M</given-names></name>
</person-group>             <year>2002</year>             <article-title>Revealing a hidden problem. An evaluation of a community dementia case-finding program from the Indian 10/66 dementia research network.</article-title>             <source>Int J Geriatr Psych</source>             <volume>17</volume>             <fpage>222</fpage>             <lpage>225</lpage>          </element-citation></ref>
<ref id="pmed.1000176-RamosCerqueira1"><label>17</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ramos-Cerqueira</surname><given-names>AT</given-names></name>
<name name-style="western"><surname>Torres</surname><given-names>AR</given-names></name>
<name name-style="western"><surname>Crepaldi</surname><given-names>AL</given-names></name>
<name name-style="western"><surname>Oliveira</surname><given-names>NI</given-names></name>
<name name-style="western"><surname>Scazufca</surname><given-names>M</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Identification of dementia cases in the community: a Brazilian experience.</article-title>             <source>J Am Geriatr Soc</source>             <volume>53</volume>             <fpage>1738</fpage>             <lpage>1742</lpage>          </element-citation></ref>
<ref id="pmed.1000176-National1"><label>18</label><element-citation publication-type="other" xlink:type="simple">             <collab xlink:type="simple">National Collaborating Centre for Mental Health</collab>             <year>2007</year>             <source>Dementia. A NICE-SCIE Guideline on supporting people with dementia and their carers in health and social care. National Clinical Practice Guideline number 42</source>             <publisher-loc>London</publisher-loc>             <publisher-name>National Institute For Health And Clinical Excellence</publisher-name>          </element-citation></ref>
<ref id="pmed.1000176-Folstein1"><label>19</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Folstein</surname><given-names>MF</given-names></name>
<name name-style="western"><surname>Folstein</surname><given-names>SE</given-names></name>
<name name-style="western"><surname>McHugh</surname><given-names>PR</given-names></name>
</person-group>             <year>1975</year>             <article-title>‘Mini-mental State’: a practical method for grading the cognitive state of patients for the clinician.</article-title>             <source>J Psychiatr Res</source>             <volume>12</volume>             <fpage>189</fpage>             <lpage>198</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Ganguli1"><label>20</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ganguli</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Ratcliff</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Chandra</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Sharma</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Gilby</surname><given-names>J</given-names></name>
<etal/></person-group>             <year>1995</year>             <article-title>A Hindi version of the MMSE: the development of a cognitive screening instrument for a largely illiterate rural elderly population in India.</article-title>             <source>Int J Geriatr Psych</source>             <volume>10</volume>             <fpage>367</fpage>             <lpage>377</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Xu1"><label>21</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Xu</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Meyer</surname><given-names>JS</given-names></name>
<name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Du</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Chowdhury</surname><given-names>M</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Adapting mini-mental state examination for dementia screening among illiterate or minimally educated elderly Chinese.</article-title>             <source>Int J Geriatr Psychiatry</source>             <volume>18</volume>             <fpage>609</fpage>             <lpage>616</lpage>          </element-citation></ref>
<ref id="pmed.1000176-CastroCosta1"><label>22</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Castro-Costa</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Fuzikawa</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Uchoa</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Firmo</surname><given-names>JO</given-names></name>
<name name-style="western"><surname>Lima-Costa</surname><given-names>MF</given-names></name>
</person-group>             <year>2008</year>             <article-title>Norms for the mini-mental state examination: adjustment of the cut-off point in population-based studies (evidences from the Bambui health aging study).</article-title>             <source>Arq Neuropsiquiatr</source>             <volume>66</volume>             <fpage>524</fpage>             <lpage>528</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Ng1"><label>23</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ng</surname><given-names>TP</given-names></name>
<name name-style="western"><surname>Niti</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Chiam</surname><given-names>PC</given-names></name>
<name name-style="western"><surname>Kua</surname><given-names>EH</given-names></name>
</person-group>             <year>2007</year>             <article-title>Ethnic and educational differences in cognitive test performance on mini-mental state examination in Asians.</article-title>             <source>Am J Geriatr Psychiatry</source>             <volume>15</volume>             <fpage>130</fpage>             <lpage>139</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Black1"><label>24</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Black</surname><given-names>SA</given-names></name>
<name name-style="western"><surname>Espino</surname><given-names>DV</given-names></name>
<name name-style="western"><surname>Mahurin</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Lichtenstein</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Hazuda</surname><given-names>HP</given-names></name>
<etal/></person-group>             <year>1999</year>             <article-title>The influence of noncognitive factors on the Mini-Mental State Examination in older Mexican-Americans: findings from the Hispanic EPESE. Established Population for the Epidemiologic Study of the Elderly.</article-title>             <source>J Clin Epidemiol</source>             <volume>52</volume>             <fpage>1095</fpage>             <lpage>1102</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Brodaty1"><label>25</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Brodaty</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Low</surname><given-names>LF</given-names></name>
<name name-style="western"><surname>Gibson</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Burns</surname><given-names>K</given-names></name>
</person-group>             <year>2006</year>             <article-title>What is the best dementia screening instrument for general practitioners to use?</article-title>             <source>Am J Geriatr Psychiatry</source>             <volume>14</volume>             <fpage>391</fpage>             <lpage>400</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Prince3"><label>26</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Prince</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Acosta</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Chiu</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Scazufca</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Varghese</surname><given-names>M</given-names></name>
</person-group>             <year>2003</year>             <article-title>Dementia diagnosis in developing countries: a cross-cultural validation study.</article-title>             <source>The Lancet</source>             <volume>361</volume>             <fpage>909</fpage>             <lpage>917</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Liu1"><label>27</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Liu</surname><given-names>SI</given-names></name>
<name name-style="western"><surname>Prince</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Chiu</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Chen</surname><given-names>TF</given-names></name>
<name name-style="western"><surname>Sun</surname><given-names>YW</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Validity and reliability of a Taiwan Chinese version of the community screening instrument for dementia.</article-title>             <source>Am J Geriatr Psychiatry</source>             <volume>13</volume>             <fpage>581</fpage>             <lpage>588</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Lecouturier1"><label>28</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lecouturier</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Bamford</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Hughes</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Francis</surname><given-names>JJ</given-names></name>
<name name-style="western"><surname>Foy</surname><given-names>R</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Appropriate disclosure of a diagnosis of dementia: identifying the key behaviours of ‘best practice’.</article-title>             <source>BMC Health Serv Res</source>             <volume>8</volume>             <fpage>95</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Ballard1"><label>29</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ballard</surname><given-names>CG</given-names></name>
<name name-style="western"><surname>Gauthier</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Cummings</surname><given-names>JL</given-names></name>
<name name-style="western"><surname>Brodaty</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Grossberg</surname><given-names>GT</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Management of agitation and aggression associated with Alzheimer disease.</article-title>             <source>Nat Rev Neurol</source>             <volume>5</volume>             <fpage>245</fpage>             <lpage>255</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Leonard1"><label>30</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Leonard</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Tinetti</surname><given-names>ME</given-names></name>
<name name-style="western"><surname>Allore</surname><given-names>HG</given-names></name>
<name name-style="western"><surname>Drickamer</surname><given-names>MA</given-names></name>
</person-group>             <year>2006</year>             <article-title>Potentially modifiable resident characteristics that are associated with physical or verbal aggression among nursing home residents with dementia.</article-title>             <source>Arch Intern Med</source>             <volume>166</volume>             <fpage>1295</fpage>             <lpage>1300</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Husebo1"><label>31</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Husebo</surname><given-names>BS</given-names></name>
<name name-style="western"><surname>Strand</surname><given-names>LI</given-names></name>
<name name-style="western"><surname>Moe-Nilssen</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Borgehusebo</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Aarsland</surname><given-names>D</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Who suffers most? Dementia and pain in nursing home patients: a cross-sectional study.</article-title>             <source>J Am Med Dir Assoc</source>             <volume>9</volume>             <fpage>427</fpage>             <lpage>433</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Peters1"><label>32</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Peters</surname><given-names>CA</given-names></name>
<name name-style="western"><surname>Potter</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Scholer</surname><given-names>SG</given-names></name>
</person-group>             <year>1988</year>             <article-title>Hearing impairment as a predictor of cognitive decline in dementia.</article-title>             <source>J Am Geriatr Soc</source>             <volume>36</volume>             <fpage>981</fpage>             <lpage>986</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Uhlmann1"><label>33</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Uhlmann</surname><given-names>RF</given-names></name>
<name name-style="western"><surname>Larson</surname><given-names>EB</given-names></name>
<name name-style="western"><surname>Koepsell</surname><given-names>TD</given-names></name>
</person-group>             <year>1986</year>             <article-title>Hearing impairment and cognitive decline in senile dementia of the Alzheimer's type.</article-title>             <source>J Am Geriatr Soc</source>             <volume>34</volume>             <fpage>207</fpage>             <lpage>210</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Chapman1"><label>34</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Chapman</surname><given-names>FM</given-names></name>
<name name-style="western"><surname>Dickinson</surname><given-names>J</given-names></name>
<name name-style="western"><surname>McKeith</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Ballard</surname><given-names>C</given-names></name>
</person-group>             <year>1999</year>             <article-title>Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer's disease: treatment implications.</article-title>             <source>Am J Psychiatry</source>             <volume>156</volume>             <fpage>1983</fpage>             <lpage>1985</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Ballard2"><label>35</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ballard</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Bannister</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Graham</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Oyebode</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Wilcock</surname><given-names>G</given-names></name>
</person-group>             <year>1995</year>             <article-title>Associations of psychotic symptoms in dementia sufferers.</article-title>             <source>Br J Psychiatry</source>             <volume>167</volume>             <fpage>537</fpage>             <lpage>540</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Eriksson1"><label>36</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Eriksson</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Gustafson</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Fagerstrom</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Olofsson</surname><given-names>B</given-names></name>
</person-group>             <year>2009</year>             <article-title>Prevalence and factors associated with urinary tract infections (UTIs) in very old women.</article-title>             <source>Arch Gerontol Geriatr</source>             <comment>In press</comment>          </element-citation></ref>
<ref id="pmed.1000176-Natalwala1"><label>37</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Natalwala</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Potluri</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Uppal</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Heun</surname><given-names>R</given-names></name>
</person-group>             <year>2008</year>             <article-title>Reasons for hospital admissions in dementia patients in Birmingham, UK, during 2002–2007.</article-title>             <source>Dement Geriatr Cogn Disord</source>             <volume>26</volume>             <fpage>499</fpage>             <lpage>505</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Rait1"><label>38</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Rait</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Fletcher</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Smeeth</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Brayne</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Stirling</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Prevalence of cognitive impairment: results from the MRC trial of assessment and management of older people in the community.</article-title>             <source>Age Ageing</source>             <volume>34</volume>             <fpage>242</fpage>             <lpage>248</lpage>          </element-citation></ref>
<ref id="pmed.1000176-FuchsLacelle1"><label>39</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Fuchs-Lacelle</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Hadjistavropoulos</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Lix</surname><given-names>L</given-names></name>
</person-group>             <year>2008</year>             <article-title>Pain assessment as intervention: a study of older adults with severe dementia.</article-title>             <source>Clin J Pain</source>             <volume>24</volume>             <fpage>697</fpage>             <lpage>707</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Allen1"><label>40</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Allen</surname><given-names>NH</given-names></name>
<name name-style="western"><surname>Burns</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Newton</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Hickson</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Ramsden</surname><given-names>R</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>The effects of improving hearing in dementia.</article-title>             <source>Age Ageing</source>             <volume>32</volume>             <fpage>189</fpage>             <lpage>193</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Gil1"><label>41</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gil</surname><given-names>GP</given-names></name>
<name name-style="western"><surname>Ramirez Diaz</surname><given-names>SP</given-names></name>
<name name-style="western"><surname>Ribera Casado</surname><given-names>JM</given-names></name>
</person-group>             <year>2003</year>             <article-title>Dementia and nutrition. Intervention study in institutionalized patients with Alzheimer disease.</article-title>             <source>J Nutr Health Aging</source>             <volume>7</volume>             <fpage>304</fpage>             <lpage>308</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Riviere1"><label>42</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Riviere</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Gillette-Guyonnet</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Voisin</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Reynish</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Andrieu</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2001</year>             <article-title>A nutritional education program could prevent weight loss and slow cognitive decline in Alzheimer's disease.</article-title>             <source>J Nutr Health Aging</source>             <volume>5</volume>             <fpage>295</fpage>             <lpage>299</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Richard1"><label>43</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Richard</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Kuiper</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Dijkgraaf</surname><given-names>MG</given-names></name>
<name name-style="western"><surname>van Gool</surname><given-names>WA</given-names></name>
</person-group>             <year>2009</year>             <article-title>Vascular care in patients with Alzheimer's disease with cerebrovascular lesions-a randomized clinical trial.</article-title>             <source>J Am Geriatr Soc</source>             <volume>57</volume>             <fpage>797</fpage>             <lpage>805</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Spector1"><label>44</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Spector</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Thorgrimsen</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Woods</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Royan</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Davies</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial.</article-title>             <source>Br J Psychiatry</source>             <volume>183</volume>             <fpage>248</fpage>             <lpage>254</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Bottino1"><label>45</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Bottino</surname><given-names>CM</given-names></name>
<name name-style="western"><surname>Carvalho</surname><given-names>IA</given-names></name>
<name name-style="western"><surname>Alvarez</surname><given-names>AM</given-names></name>
<name name-style="western"><surname>Avila</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Zukauskas</surname><given-names>PR</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study.</article-title>             <source>Clin Rehabil</source>             <volume>19</volume>             <fpage>861</fpage>             <lpage>869</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Clare1"><label>46</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Clare</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Woods</surname><given-names>RT</given-names></name>
<name name-style="western"><surname>Moniz Cook</surname><given-names>ED</given-names></name>
<name name-style="western"><surname>Orrell</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Spector</surname><given-names>A</given-names></name>
</person-group>             <year>2003</year>             <article-title>Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD003260</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Woods1"><label>47</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Woods</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Spector</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Jones</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Orrell</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Davies</surname><given-names>S</given-names></name>
</person-group>             <year>2005</year>             <article-title>Reminiscence therapy for dementia.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD001120</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Birks1"><label>48</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Birks</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Harvey</surname><given-names>RJ</given-names></name>
</person-group>             <year>2006</year>             <article-title>Donepezil for dementia due to Alzheimer's disease.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD001190</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Birks2"><label>49</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Birks</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Grimley</surname><given-names>EJ</given-names></name>
<name name-style="western"><surname>Iakovidou</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Tsolaki</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Holt</surname><given-names>FE</given-names></name>
</person-group>             <year>2009</year>             <article-title>Rivastigmine for Alzheimer's disease.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD001191</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Loy1"><label>50</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Loy</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Schneider</surname><given-names>L</given-names></name>
</person-group>             <year>2006</year>             <article-title>Galantamine for Alzheimer's disease and mild cognitive impairment.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD001747</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Birks3"><label>51</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Birks</surname><given-names>J</given-names></name>
</person-group>             <year>2006</year>             <article-title>Cholinesterase inhibitors for Alzheimer's disease.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD005593</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Moraes1"><label>52</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Moraes</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Poyares</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Sukys-Claudino</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Guilleminault</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Tufik</surname><given-names>S</given-names></name>
</person-group>             <year>2008</year>             <article-title>Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study.</article-title>             <source>Chest</source>             <volume>133</volume>             <fpage>677</fpage>             <lpage>683</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Caramelli1"><label>53</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Caramelli</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Chaves</surname><given-names>ML</given-names></name>
<name name-style="western"><surname>Engelhardt</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Machado</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Schultz</surname><given-names>RR</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Effects of galantamine on attention and memory in Alzheimer's disease measured by computerized neuropsychological tests: results of the Brazilian Multi-Center Galantamine Study (GAL-BRA-01).</article-title>             <source>Arq Neuropsiquiatr</source>             <volume>62</volume>             <fpage>379</fpage>             <lpage>384</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Chu1"><label>54</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Chu</surname><given-names>LW</given-names></name>
<name name-style="western"><surname>Yik</surname><given-names>PY</given-names></name>
<name name-style="western"><surname>Mok</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Chung</surname><given-names>CP</given-names></name>
</person-group>             <year>2007</year>             <article-title>A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.</article-title>             <source>Int J Clin Pract</source>             <volume>61</volume>             <fpage>403</fpage>             <lpage>410</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Burns1"><label>55</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Burns</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Bernabei</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Bullock</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Cruz Jentoft</surname><given-names>AJ</given-names></name>
<name name-style="western"><surname>Frolich</surname><given-names>L</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial.</article-title>             <source>Lancet Neurol</source>             <volume>8</volume>             <fpage>39</fpage>             <lpage>47</lpage>          </element-citation></ref>
<ref id="pmed.1000176-McShane1"><label>56</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>McShane</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Areosa</surname><given-names>SA</given-names></name>
<name name-style="western"><surname>Minakaran</surname><given-names>N</given-names></name>
</person-group>             <year>2006</year>             <article-title>Memantine for dementia.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD003154</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Kavirajan1"><label>57</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kavirajan</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Schneider</surname><given-names>LS</given-names></name>
</person-group>             <year>2007</year>             <article-title>Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.</article-title>             <source>Lancet Neurol</source>             <volume>6</volume>             <fpage>782</fpage>             <lpage>792</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Wilcock1"><label>58</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wilcock</surname><given-names>GK</given-names></name>
<name name-style="western"><surname>Ballard</surname><given-names>CG</given-names></name>
<name name-style="western"><surname>Cooper</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Loft</surname><given-names>H</given-names></name>
</person-group>             <year>2008</year>             <article-title>Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.</article-title>             <source>J Clin Psychiatry</source>             <volume>69</volume>             <fpage>341</fpage>             <lpage>348</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Howard1"><label>59</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Howard</surname><given-names>RJ</given-names></name>
<name name-style="western"><surname>Juszczak</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Ballard</surname><given-names>CG</given-names></name>
<name name-style="western"><surname>Bentham</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Brown</surname><given-names>RG</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Donepezil for the treatment of agitation in Alzheimer's disease.</article-title>             <source>N Engl J Med</source>             <volume>357</volume>             <fpage>1382</fpage>             <lpage>1392</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Lonergan1"><label>60</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lonergan</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Luxenberg</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Colford</surname><given-names>J</given-names></name>
</person-group>             <year>2002</year>             <article-title>Haloperidol for agitation in dementia.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD002852</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Ballard3"><label>61</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ballard</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Waite</surname><given-names>J</given-names></name>
</person-group>             <year>2006</year>             <article-title>The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD003476</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Schneider1"><label>62</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Schneider</surname><given-names>LS</given-names></name>
<name name-style="western"><surname>Dagerman</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Insel</surname><given-names>PS</given-names></name>
</person-group>             <year>2006</year>             <article-title>Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.</article-title>             <source>Am J Geriatr Psychiatry</source>             <volume>14</volume>             <fpage>191</fpage>             <lpage>210</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Ballard4"><label>63</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ballard</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Howard</surname><given-names>R</given-names></name>
</person-group>             <year>2006</year>             <article-title>Neuroleptic drugs in dementia: benefits and harm.</article-title>             <source>Nat Rev Neurosci</source>             <volume>7</volume>             <fpage>492</fpage>             <lpage>500</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Schneider2"><label>64</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Schneider</surname><given-names>LS</given-names></name>
<name name-style="western"><surname>Dagerman</surname><given-names>KS</given-names></name>
<name name-style="western"><surname>Insel</surname><given-names>P</given-names></name>
</person-group>             <year>2005</year>             <article-title>Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.</article-title>             <source>JAMA</source>             <volume>294</volume>             <fpage>1934</fpage>             <lpage>1943</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Gill1"><label>65</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gill</surname><given-names>SS</given-names></name>
<name name-style="western"><surname>Bronskill</surname><given-names>SE</given-names></name>
<name name-style="western"><surname>Normand</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Anderson</surname><given-names>GM</given-names></name>
<name name-style="western"><surname>Sykora</surname><given-names>K</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Antipsychotic drug use and mortality in older adults with dementia.</article-title>             <source>Ann Intern Med</source>             <volume>146</volume>             <fpage>775</fpage>             <lpage>786</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Kales1"><label>66</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kales</surname><given-names>HC</given-names></name>
<name name-style="western"><surname>Valenstein</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Kim</surname><given-names>HM</given-names></name>
<name name-style="western"><surname>McCarthy</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Ganoczy</surname><given-names>D</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications.</article-title>             <source>Am J Psychiatry</source>             <volume>164</volume>             <fpage>1568</fpage>             <lpage>1576</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Kleijer1"><label>67</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kleijer</surname><given-names>BC</given-names></name>
<name name-style="western"><surname>van Marum</surname><given-names>RJ</given-names></name>
<name name-style="western"><surname>Egberts</surname><given-names>AC</given-names></name>
<name name-style="western"><surname>Jansen</surname><given-names>PA</given-names></name>
<name name-style="western"><surname>Knol</surname><given-names>W</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Risk of cerebrovascular events in elderly users of antipsychotics.</article-title>             <source>J Psychopharmacol</source>             <comment>In press</comment>          </element-citation></ref>
<ref id="pmed.1000176-Douglas1"><label>68</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Douglas</surname><given-names>IJ</given-names></name>
<name name-style="western"><surname>Smeeth</surname><given-names>L</given-names></name>
</person-group>             <year>2008</year>             <article-title>Exposure to antipsychotics and risk of stroke: self controlled case series study.</article-title>             <source>BMJ</source>             <volume>337</volume>             <fpage>a1227</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Hunkeler1"><label>69</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hunkeler</surname><given-names>EM</given-names></name>
<name name-style="western"><surname>Katon</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Tang</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Williams</surname><given-names>JW</given-names><suffix>Jr</suffix></name>
<name name-style="western"><surname>Kroenke</surname><given-names>K</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care.</article-title>             <source>BMJ</source>             <volume>332</volume>             <fpage>259</fpage>             <lpage>263</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Bains1"><label>70</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Bains</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Birks</surname><given-names>JS</given-names></name>
<name name-style="western"><surname>Dening</surname><given-names>TR</given-names></name>
</person-group>             <year>2002</year>             <article-title>The efficacy of antidepressants in the treatment of depression in dementia.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD003944</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Lyketsos1"><label>71</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lyketsos</surname><given-names>CG</given-names></name>
<name name-style="western"><surname>DelCampo</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Steinberg</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Miles</surname><given-names>Q</given-names></name>
<name name-style="western"><surname>Steele</surname><given-names>CD</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.</article-title>             <source>Arch Gen Psychiatry</source>             <volume>60</volume>             <fpage>737</fpage>             <lpage>746</lpage>          </element-citation></ref>
<ref id="pmed.1000176-MartinonTorres1"><label>72</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Martinon-Torres</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Fioravanti</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Grimley</surname><given-names>EJ</given-names></name>
</person-group>             <year>2004</year>             <article-title>Trazodone for agitation in dementia.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD004990</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Pollock1"><label>73</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Pollock</surname><given-names>BG</given-names></name>
<name name-style="western"><surname>Mulsant</surname><given-names>BH</given-names></name>
<name name-style="western"><surname>Rosen</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Sweet</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Mazumdar</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2002</year>             <article-title>Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients.</article-title>             <source>Am J Psychiatry</source>             <volume>159</volume>             <fpage>460</fpage>             <lpage>465</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Finkel1"><label>74</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Finkel</surname><given-names>SI</given-names></name>
<name name-style="western"><surname>Mintzer</surname><given-names>JE</given-names></name>
<name name-style="western"><surname>Dysken</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Krishnan</surname><given-names>KR</given-names></name>
<name name-style="western"><surname>Burt</surname><given-names>T</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.</article-title>             <source>Int J Geriatr Psychiatry</source>             <volume>19</volume>             <fpage>9</fpage>             <lpage>18</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Lonergan2"><label>75</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lonergan</surname><given-names>ET</given-names></name>
<name name-style="western"><surname>Cameron</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Luxenberg</surname><given-names>J</given-names></name>
</person-group>             <year>2004</year>             <article-title>Valproic acid for agitation in dementia.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD003945</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Tariot1"><label>76</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Tariot</surname><given-names>PN</given-names></name>
<name name-style="western"><surname>Erb</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Podgorski</surname><given-names>CA</given-names></name>
<name name-style="western"><surname>Cox</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Patel</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>1998</year>             <article-title>Efficacy and tolerability of carbamazepine for agitation and aggression in dementia.</article-title>             <source>Am J Psychiatry</source>             <volume>155</volume>             <fpage>54</fpage>             <lpage>61</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Olin1"><label>77</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Olin</surname><given-names>JT</given-names></name>
<name name-style="western"><surname>Fox</surname><given-names>LS</given-names></name>
<name name-style="western"><surname>Pawluczyk</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Taggart</surname><given-names>NA</given-names></name>
<name name-style="western"><surname>Schneider</surname><given-names>LS</given-names></name>
</person-group>             <year>2001</year>             <article-title>A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease.</article-title>             <source>Am J Geriatr Psychiatry</source>             <volume>9</volume>             <fpage>400</fpage>             <lpage>405</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Forbes1"><label>78</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Forbes</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Morgan</surname><given-names>DG</given-names></name>
<name name-style="western"><surname>Bangma</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Peacock</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Pelletier</surname><given-names>N</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Light therapy for managing sleep, behaviour, and mood disturbances in dementia.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD003946</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Chung1"><label>79</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Chung</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Lai</surname><given-names>CK</given-names></name>
<name name-style="western"><surname>Chung</surname><given-names>PM</given-names></name>
<name name-style="western"><surname>French</surname><given-names>HP</given-names></name>
</person-group>             <year>2002</year>             <article-title>Snoezelen for dementia.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD003152</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Ballard5"><label>80</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ballard</surname><given-names>CG</given-names></name>
<name name-style="western"><surname>O'Brien</surname><given-names>JT</given-names></name>
<name name-style="western"><surname>Reichelt</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Perry</surname><given-names>EK</given-names></name>
</person-group>             <year>2002</year>             <article-title>Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa.</article-title>             <source>J Clin Psychiatry</source>             <volume>63</volume>             <fpage>553</fpage>             <lpage>558</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Viggo1"><label>81</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Viggo</surname><given-names>HN</given-names></name>
<name name-style="western"><surname>Jorgensen</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Ortenblad</surname><given-names>L</given-names></name>
</person-group>             <year>2006</year>             <article-title>Massage and touch for dementia.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD004989</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Remington1"><label>82</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Remington</surname><given-names>R</given-names></name>
</person-group>             <year>2002</year>             <article-title>Calming music and hand massage with agitated elderly.</article-title>             <source>Nurs Res</source>             <volume>51</volume>             <fpage>317</fpage>             <lpage>323</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Sorensen1"><label>83</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Sorensen</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Duberstein</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Gill</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Pinquart</surname><given-names>M</given-names></name>
</person-group>             <year>2006</year>             <article-title>Dementia care: mental health effects, intervention strategies, and clinical implications.</article-title>             <source>Lancet Neurol</source>             <volume>5</volume>             <fpage>961</fpage>             <lpage>973</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Pinquart1"><label>84</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Pinquart</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Sorensen</surname><given-names>S</given-names></name>
</person-group>             <year>2006</year>             <article-title>Helping caregivers of persons with dementia: which interventions work and how large are their effects?</article-title>             <source>Int Psychogeriatr</source>             <volume>18</volume>             <fpage>577</fpage>             <lpage>595</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Smits1"><label>85</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Smits</surname><given-names>CH</given-names></name>
<name name-style="western"><surname>de</surname><given-names>LJ</given-names></name>
<name name-style="western"><surname>Droes</surname><given-names>RM</given-names></name>
<name name-style="western"><surname>Meiland</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Vernooij-Dassen</surname><given-names>M</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Effects of combined intervention programmes for people with dementia living at home and their caregivers: a systematic review.</article-title>             <source>Int J Geriatr Psychiatry</source>             <volume>22</volume>             <fpage>1181</fpage>             <lpage>1193</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Brodaty2"><label>86</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Brodaty</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Green</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Koschera</surname><given-names>A</given-names></name>
</person-group>             <year>2003</year>             <article-title>Meta-analysis of psychosocial interventions for caregivers of people with dementia.</article-title>             <source>J Am Geriatr Soc</source>             <volume>51</volume>             <fpage>657</fpage>             <lpage>664</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Lee1"><label>87</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lee</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Cameron</surname><given-names>M</given-names></name>
</person-group>             <year>2004</year>             <article-title>Respite care for people with dementia and their carers.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD004396</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Spijker1"><label>88</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Spijker</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Vernooij-Dassen</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Vasse</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Adang</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Wollersheim</surname><given-names>H</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: a meta-analysis.</article-title>             <source>J Am Geriatr Soc</source>             <volume>56</volume>             <fpage>1116</fpage>             <lpage>1128</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Dias1"><label>89</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Dias</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Dewey</surname><given-names>ME</given-names></name>
<name name-style="western"><surname>D'Souza</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Dhume</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Motghare</surname><given-names>DD</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>The effectiveness of a home care program for supporting caregivers of persons with dementia in developing countries: a randomised controlled trial from Goa, India.</article-title>             <source>PLoS ONE</source>             <volume>3</volume>             <fpage>e2333</fpage>             <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0002333" xlink:type="simple">10.1371/journal.pone.0002333</ext-link></comment>          </element-citation></ref>
<ref id="pmed.1000176-Gavrilova1"><label>90</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gavrilova</surname><given-names>SI</given-names></name>
<name name-style="western"><surname>Ferri</surname><given-names>CP</given-names></name>
<name name-style="western"><surname>Mikhaylova</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Sokolova</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Banerjee</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Helping carers to care-The 10/66 dementia research group's randomized control trial of a caregiver intervention in Russia.</article-title>             <source>Int J Geriatr Psychiatry</source>             <volume>24</volume>             <fpage>347</fpage>             <lpage>354</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Graham1"><label>91</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Graham</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Brodaty</surname><given-names>H</given-names></name>
</person-group>             <year>1997</year>             <article-title>Alzheimer's Disease International.</article-title>             <source>Int J Geriatr Psych</source>             <volume>12</volume>             <fpage>691</fpage>             <lpage>692</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Prince4"><label>92</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Prince</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Acosta</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Albanese</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Arizaga</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Ferri</surname><given-names>CP</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Ageing and dementia in low and middle income countries-Using research to engage with public and policy makers.</article-title>             <source>Int Rev Psychiatry</source>             <volume>20</volume>             <fpage>332</fpage>             <lpage>343</lpage>          </element-citation></ref>
<ref id="pmed.1000176-EppingJordan1"><label>93</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Epping-Jordan</surname><given-names>JE</given-names></name>
<name name-style="western"><surname>Pruitt</surname><given-names>SD</given-names></name>
<name name-style="western"><surname>Bengoa</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Wagner</surname><given-names>EH</given-names></name>
</person-group>             <year>2004</year>             <article-title>Improving the quality of health care for chronic conditions.</article-title>             <source>Qual Saf Health Care</source>             <volume>13</volume>             <fpage>299</fpage>             <lpage>305</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Sousa1"><label>94</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Sousa</surname><given-names>RM</given-names></name>
<name name-style="western"><surname>Scazufca</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Menezes</surname><given-names>PR</given-names></name>
<name name-style="western"><surname>Crepaldi</surname><given-names>AL</given-names></name>
<name name-style="western"><surname>Prince</surname><given-names>MJ</given-names></name>
</person-group>             <year>2009</year>             <article-title>Feasibility and reliability of the elderly version of the Camberwell Assessment of Needs (CANE): results from the Sao Paulo Ageing &amp; Health Study.</article-title>             <source>Rev Bras Psiquiatr</source>             <volume>31</volume>             <fpage>34</fpage>             <lpage>38</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Kalaria1"><label>95</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kalaria</surname><given-names>RN</given-names></name>
<name name-style="western"><surname>Maestre</surname><given-names>GE</given-names></name>
<name name-style="western"><surname>Arizaga</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Friedland</surname><given-names>RP</given-names></name>
<name name-style="western"><surname>Galasko</surname><given-names>D</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.</article-title>             <source>Lancet Neurol</source>             <volume>7</volume>             <fpage>812</fpage>             <lpage>826</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Rafii1"><label>96</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Rafii</surname><given-names>MS</given-names></name>
<name name-style="western"><surname>Aisen</surname><given-names>PS</given-names></name>
</person-group>             <year>2009</year>             <article-title>Recent developments in Alzheimer's disease therapeutics.</article-title>             <source>BMC Med</source>             <volume>7</volume>             <fpage>7</fpage>          </element-citation></ref>
<ref id="pmed.1000176-World2"><label>97</label><element-citation publication-type="other" xlink:type="simple">             <collab xlink:type="simple">World Health Organization</collab>             <year>2004</year>             <source>Towards age-friendly primary health care</source>             <publisher-loc>Geneva</publisher-loc>             <publisher-name>World Health Organization</publisher-name>             <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://whqlibdoc.who.int/publications/2004/9241592184.pdf" xlink:type="simple">http://whqlibdoc.who.int/publications/2004/9241592184.pdf</ext-link>. Accessed 5 October 2009</comment>          </element-citation></ref>
<ref id="pmed.1000176-United1"><label>98</label><element-citation publication-type="other" xlink:type="simple">             <collab xlink:type="simple">United Nations</collab>             <year>2002</year>             <article-title>In: Report of the Second World Assembly on Ageing; Madrid 8–12 April 2002. A/CONF.197/9.</article-title>             <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.un.org/esa/socdev/ageing/secondworld02.html" xlink:type="simple">http://www.un.org/esa/socdev/ageing/secondworld02.html</ext-link>. Accessed 5 October 2009</comment>          </element-citation></ref>
<ref id="pmed.1000176-Shaji3"><label>99</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Shaji</surname><given-names>KS</given-names></name>
</person-group>             <year>2009</year>             <article-title>Dementia care in developing countries: the road ahead.</article-title>             <source>Indian Journal of Psychiatry</source>             <volume>51</volume>             <fpage>S5</fpage>             <lpage>S7</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Callahan1"><label>100</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Callahan</surname><given-names>CM</given-names></name>
<name name-style="western"><surname>Boustani</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Unverzagt</surname><given-names>FW</given-names></name>
<name name-style="western"><surname>Austrom</surname><given-names>MG</given-names></name>
<name name-style="western"><surname>Damush</surname><given-names>TM</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial.</article-title>             <source>JAMA</source>             <volume>295</volume>             <fpage>2148</fpage>             <lpage>2157</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Patel2"><label>101</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Patel</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Simon</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Chowdhary</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Kaaya</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Araya</surname><given-names>R</given-names></name>
</person-group>             <year>2009</year>             <article-title>Packages of care for depression in low and middle income countries.</article-title>             <source>PLoS Med</source>             <volume>6</volume>             <fpage>e1000159</fpage>             <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.journal.pmed.1000159" xlink:type="simple">10.1371/journal.pmed.journal.pmed.1000159</ext-link></comment>          </element-citation></ref>
<ref id="pmed.1000176-Hall1"><label>102</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hall</surname><given-names>KS</given-names></name>
<name name-style="western"><surname>Hendrie</surname><given-names>HH</given-names></name>
<name name-style="western"><surname>Brittain</surname><given-names>HM</given-names></name>
<name name-style="western"><surname>Norton</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Rodgers</surname><given-names>DD</given-names></name>
<etal/></person-group>             <year>1993</year>             <article-title>The development of a dementia screening interview in two distinct languages.</article-title>             <source>Int J Meth Psych Res</source>             <volume>3</volume>             <fpage>1</fpage>             <lpage>28</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Prince5"><label>103</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Prince</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Acosta</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Chiu</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Scazufca</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Varghese</surname><given-names>M</given-names></name>
</person-group>             <year>2003</year>             <article-title>Dementia diagnosis in developing countries: a cross-cultural validation study.</article-title>             <source>Lancet</source>             <volume>361</volume>             <fpage>909</fpage>             <lpage>917</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Reynolds1"><label>104</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Reynolds</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Thornicroft</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Abas</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Woods</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Hoe</surname><given-names>J</given-names></name>
<etal/></person-group>             <year>2000</year>             <article-title>Camberwell Assessment of Need for the Elderly (CANE). Development, validity and reliability.</article-title>             <source>Br J Psychiatry</source>             <volume>176</volume>             <fpage>444</fpage>             <lpage>452</lpage>          </element-citation></ref>
<ref id="pmed.1000176-Thorgrimsen1"><label>105</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Thorgrimsen</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Spector</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Wiles</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Orrell</surname><given-names>M</given-names></name>
</person-group>             <year>2003</year>             <article-title>Aroma therapy for dementia.</article-title>             <source>Cochrane Database Syst Rev</source>             <fpage>CD003150</fpage>          </element-citation></ref>
<ref id="pmed.1000176-Institute1"><label>106</label><element-citation publication-type="other" xlink:type="simple">             <collab xlink:type="simple">Institute of Development and Policy Management/HelpAge International</collab>             <year>2003</year>             <article-title>Non-contributory pensions and poverty prevention. A comparative study of Brazil and South Africa. Final Report, DFID Project R7897, Pensions and Poverty Prevention. Manchester (United Kingdom): Institute of Development and Policy Management and London: HelpAge International.</article-title>             <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.helpage.org/Resources/Researchreports/Non-contributorypensions" xlink:type="simple">http://www.helpage.org/Resources/Researchreports/Non-contributorypensions</ext-link>. Accessed 5 October 2009</comment>          </element-citation></ref>
<ref id="pmed.1000176-UK1"><label>107</label><element-citation publication-type="other" xlink:type="simple">             <collab xlink:type="simple">UK Department of Health</collab>             <year>2009</year>             <article-title>Living well with dementia. A National Dementia Strategy.</article-title>             <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_094058" xlink:type="simple">http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_094058</ext-link>. Accessed 5 October 2009</comment>          </element-citation></ref>
</ref-list><glossary><title>Abbreviations</title><def-list><def-item>
<term>BPSD</term>
<def>
<p>behavioural and psychological symptoms</p>
</def>
</def-item><def-item>
<term>ChEI</term>
<def>
<p>cholinesterase inhibitor</p>
</def>
</def-item><def-item>
<term>HIC</term>
<def>
<p>high income country</p>
</def>
</def-item><def-item>
<term>LMIC</term>
<def>
<p>low- and middle-income country</p>
</def>
</def-item><def-item>
<term>RCT</term>
<def>
<p>randomised controlled trial</p>
</def>
</def-item></def-list></glossary>
<fn-group><fn fn-type="other"><p><bold>Provenance:</bold> Commissioned; externally peer reviewed.</p></fn></fn-group>
</back>
</article>